mRNA |
L-685458 |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.1 |
mRNA |
JQ-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.057 |
0.1 |
mRNA |
UNC0321 |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.1 |
mRNA |
MLN4924 |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.1 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.1 |
mRNA |
BMS-754807 |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.1 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.045 |
0.1 |
mRNA |
BRD-K04800985 |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.1 |
mRNA |
XMD8-92 |
GDSC1000 |
pan-cancer |
AAC |
0.076 |
0.1 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.051 |
0.1 |